Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin vs Prednisolone in Acute NAION
NCT03715881Phase 2Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2018
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in non-arteritic anterior ischemic optic neuropathy (NAION) comparing Erythropoietin, Prednisolone and Placebo (3 arms). Primary endpoints: Improvement in indices visual acuity at 6 months, Improvement in indices visual field at 6 months and 1 more. Status: unknown.
02
Drugs
erythropoietinprednisolone
03
Conditions
non-arteritic anterior ischemic optic neuropathy (NAION)
Beyond the preview
Go deeper on NCT03715881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03715881.